Achillion Pharmaceuticals Inc.
-
Ticker
ACHN
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Blue Bell, Pennsylvania
Achillion Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antivirals for the treatment of chronic hepatitis C; and the development of antibacterials for the treatment of resistant bacterial infections.
REPORT RATINGS
4.8 / 5.0 (168)
Achillion Pharmaceuticals Inc. reports have an aggregate usefulness score of 4.8 based on 168 reviews.
Achillion Pharmaceuticals Inc.
Most Recent Annual Report
MOST RECENT
2018 Annual Report and Form 10K
Older/Archived Annual Reports